Atlas FDA

ProACT Adjustable Continence Therapy for Men

FDA premarket approval P130018/S002 · decided 2021-06-10

Approval details

PMA number
P130018
Supplement
S002
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
ProACT Adjustable Continence Therapy for Men
Generic name
Device, incontinence, mechanical/hydraulic
Applicant
Uromedica, Inc.
Date received
2021-05-18
Decision date
2021-06-10
Days to decision
23 days
Decision code
OK30
Product code
EZY
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Plymouth, MN
Statement
Update the sterilization dose auditing frequency from every three to 12 months.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.